Latest Commercial Readiness News

Page 3 of 11
xReality Group delivered a standout Q3 FY26 with a 62% jump in cash receipts and a new Mixed Reality sale to the US Department of Defense, underpinning its growing Operator XR platform.
Sophie Babbage
Sophie Babbage
30 Apr 2026
Clean TeQ Water boosted its cash position and operational momentum in Q3 FY26, winning a A$10.4 million DESALX execution contract at Nyrstar Belgium, completing a uranium plant at Heathgate Resources, and advancing lithium and phosphate projects internationally.
Victor Sage
Victor Sage
29 Apr 2026
Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.
Ada Torres
Ada Torres
29 Apr 2026
Zeotech pushed forward its AusPozz™ metakaolin commercialisation with extended and new MOUs, progressed key Toondoon project approvals amid rising contractor costs, and launched live methane control trials.
Maxwell Dee
Maxwell Dee
29 Apr 2026
GCM Corporation finalises exclusive rights to its Very High Density technology, launches its first commercial heat sink products, and expands global prototyping efforts targeting high-growth sectors including EV infrastructure and data centres.
Sophie Babbage
Sophie Babbage
29 Apr 2026
Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.
Ada Torres
Ada Torres
28 Apr 2026
Castile Resources has kicked off pilot plant bench scale testing for its Rover 1 project, integrating a 41% resource upgrade and higher metal prices into its Bankable Feasibility Study. The company also secured $8.4 million in funding and is preparing for exploration drilling amid regional consolidation.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.
Ada Torres
Ada Torres
23 Apr 2026
Hazer Group has completed a key Process Design Package with KBR, unlocking large-scale commercial potential for its methane pyrolysis technology. The company also signed a non-binding graphite offtake LOI with Green Steel WA and qualified its graphite for concrete and asphalt applications, all while maintaining a solid cash position and reducing cash burn.
Maxwell Dee
Maxwell Dee
20 Apr 2026
BlinkLab has secured A$17.5 million through an oversubscribed placement to fuel regulatory trials and commercial launch of its AI-driven autism and ADHD diagnostic tools.
Ada Torres
Ada Torres
16 Apr 2026
Iondrive Limited has confirmed over 90% extraction of key rare earth elements neodymium and praseodymium from US commercial samples, exceeding prior economic assumptions and advancing its modular recycling technology toward commercial deployment.
Maxwell Dee
Maxwell Dee
16 Apr 2026
Vysarn Limited's joint venture with Kariyarra Aboriginal Corporation has been shortlisted by Water Corporation to submit a formal proposal for supplying bulk water to Port Hedland, progressing key regulatory approvals for the Kariyarra Water Scheme.
Maxwell Dee
Maxwell Dee
15 Apr 2026

Browse the archive

Full archive